Evidence map›Paper›PMID 27264393›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2016

Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis.

Bradley J Kendall, Joel H Rubenstein, Michael B Cook, Thomas L Vaughan, Lesley A Anderson, Liam J Murray, Nicholas J Shaheen, Douglas A Corley, Apoorva K Chandar, Li Li and 5 more

Open access · greenAbstract read
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Article
  6. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 2 countries.

Bradley J KendallQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Joel H RubensteinCenter for Clinical Management Research, Ann Arbor Veterans Affairs Medical Center, Ann Arbor, Michigan; Barrett's Esophagus Program, Division of Gastroenterology Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Michael B CookDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Thomas L VaughanProgram in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Lesley A AndersonCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland.
Liam J MurrayCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland.
Nicholas J ShaheenDivision of Gastroenterology and Hepatology, University of North Carolina School of Medicine, University of North Carolina, Chapel Hill, North Carolina.
Douglas A CorleyKaiser Permanente Division of Research, Oakland, California and San Francisco Medical Center.
Apoorva K ChandarDivision of Gastroenterology and Liver Diseases, Case Western Reserve University, Cleveland, Ohio.
Li LiDepartment of Family Medicine, Swetland Center for Environmental Health, Case Western Reserve University, Cleveland, Ohio.
Katarina B GreerDivision of Gastroenterology and Liver Diseases, Case Western Reserve University, Cleveland, Ohio.
Amitabh ChakDivision of Gastroenterology and Liver Diseases, Case Western Reserve University, Cleveland, Ohio.
Hashem B El-SeragDepartment of Medicine, Houston VA Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, Texas; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
David C WhitemanQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Aaron P ThriftSection of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas. Electronic address: aaron.thrift@bcm.edu.
Case Western Reserve University · USBaylor College of Medicine · USCenter for Environmental Health · USCenter for Innovation · USDivision of Cancer Epidemiology and GeneticsFred Hutch Cancer Center · USKaiser Permanente San Francisco Medical Center · USQIMR Berghofer Medical Research Institute · AUUniversity of North Carolina at Chapel Hill · USUniversity of Queensland · AUVA Center for Clinical Management Research · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Whole Exome Approaches for Esophageal Adenocarcinoma Susceptibility GenesU54CA163060 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI CHAK, AMITABH, GUDA, KISHORE · 2011 to 2022
$14.0M
Barretts EsophagusZIACP010220 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2011 to 2025
$4.5M
Obesity, H pylori and Risk of Barrett's EsophagusR01CA116845 · NCI · BAYLOR COLLEGE OF MEDICINE · PI EL-SERAG, HASHEM B · 2007 to 2011
$2.8M
Epidemiology and Incidence of Barrett's EsophagusR01DK063616 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORLEY, DOUGLAS ALLEN · 2002 to 2010
$2.6M
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROLK05CA124911 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L · 2007 to 2016
$1.6M
Molecular epidemiology of Barretts esophagus and cancerR01CA001833 · NCI · QUEENSLAND INSTITUTE OF MEDICAL RESEARCH · PI WHITEMAN, DAVID C · 2002 to 2006
$1.3M
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative TherapyK24DK100548 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHAHEEN, NICHOLAS J · 2013 to 2017
$896k
The Epidemiology of Adipokines in Barrett's EsophagusK23DK079291 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUBENSTEIN, JOEL H · 2007 to 2011
$760k
Epidemiologic Case-control Study of Barrett's EsophagusK23DK059311 · NIDDK · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SHAHEEN, NICHOLAS J · 2001 to 2005
$626k
EPIDEMIOLOGY OF BARRETTS ESOPHAGUSR01CA072866 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L · 1997 to 2000
$543k
Insulin/IGF-1 Pathway in Barrett's EsophagusR21CA135692 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI CHAK, AMITABH · 2008 to 2009
$420k
CSRD VA I01 CX000899NCI NIH HHS K05 CA124911NCI NIH HHS R01 CA001833NCI NIH HHS R01 CA072866NCI NIH HHS R01 CA116845NCI NIH HHS R21 CA135692NCI NIH HHS U54 CA163060NIDDK NIH HHS K23 DK059311NIDDK NIH HHS K23 DK079291NIDDK NIH HHS K24 DK100548NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK063616NIDDK NIH HHS R03 DK075842NIDDK NIH HHS R21 DK077742
6 · The paper itself

Abstract

BACKGROUND &

aimsGluteofemoral obesity (determined by measurement of subcutaneous fat in the hip and thigh regions) could reduce risks of cardiovascular and diabetic disorders associated with abdominal obesity. We evaluated whether gluteofemoral obesity also reduces the risk of Barrett's esophagus (BE), a premalignant lesion associated with abdominal obesity.

methodsWe collected data from non-Hispanic white participants in 8 studies in the Barrett's and Esophageal Adenocarcinoma Consortium. We compared measures of hip circumference (as a proxy for gluteofemoral obesity) from cases of BE (n = 1559) separately with 2 control groups: 2557 population-based controls and 2064 individuals with gastroesophageal reflux disease (GERD controls). Study-specific odds ratios (ORs) and 95% confidence intervals (95% CIs) were estimated using individual participant data and multivariable logistic regression and combined using a random-effects meta-analysis.

resultsWe found an inverse relationship between hip circumference and BE (OR per 5-cm increase, 0.88; 95% CI, 0.81-0.96), compared with population-based controls in a multivariable model that included waist circumference. This association was not observed in models that did not include waist circumference. Similar results were observed in analyses stratified by frequency of GERD symptoms. The inverse association with hip circumference was statistically significant only among men (vs population-based controls: OR, 0.85; 95% CI, 0.76-0.96 for men; OR, 0.93; 95% CI, 0.74-1.16 for women). For men, within each category of waist circumference, a larger hip circumference was associated with a decreased risk of BE. Increasing waist circumference was associated with an increased risk of BE in the mutually adjusted population-based and GERD control models.

conclusionsAlthough abdominal obesity is associated with an increased risk of BE, there is an inverse association between gluteofemoral obesity and BE, particularly among men.

Indexed as

AdultAgedAged, 80 and overBarrett EsophagusCase-Control StudiesFemaleHumansMaleMiddle AgedObesityRisk AssessmentBEACONEpidemiologyEsophageal CancerObesityRisk Factors

Identifiers

PMID27264393
PMCPMC5028323
OpenAlexW2415574907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.